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Chikungunya Virus: more than a mosquito bite
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Introduction

Pathophysiological Process

Chikungunya fever is a viral infection caused by the Chikungunya virus (CHIKV). Although seldom fatal,
CHIKV causes high fevers, polyarthralgia, and rash. The mosquito-borne virus has spread rapidly in the
last ten years, causing over three million cases of CHIKV worldwide (Powers, 2015). The recent outbreak
initiated in Africa and the islands of the Indian Ocean in 2004 has quickly spread to Asia, Europe and the
Americas (CDC, 2015). According to the CDC (2015), until 2014, cases in the United States had only been
linked to foreign travel outside of the Americas. As the outbreak has grown, cases of local transmission in
Florida and Puerto Rico have necessitated increased education for healthcare clinicians in prevention,
detection and treatment of CHIKV (Kendrick, Stanek, & Blackmore, 2014). There is currently no antiviral
treatment CHIKV or vaccine to prevent CHIKV (Weaver, Osorio, Livengood, Chen, & Stinchcomb, 2012).

CHIKV is a single stranded RNA arbovirus transmitted via mosquito vectors, specifically aedes aegypti and
aedes albopictus (CDC, 2015). Three genotypes classify the virus: Asian, West African, and
Central/East/South African (Vega-Rúa et al, 2015). The vectors live in warm, tropical climates and are also
carriers for dengue virus. Aedes aegypti and aedes albopictus are active during the day, with females biting
several times during a feeding cycle (Weaver, Osorio, Livengood, Chen, & Stinchcomb. 2012). According to
Weaver, Osorio, Livengood, Chen, and Stinchcomb (2012), primates were initial hosts for CHIKV, but soon
humans became infected.

Table 3.
Primary
transmission
cycle (CDC,
2015)

Table 1.
Countries
with reported
local
transmission
of
chikungunya
virus disease
(CDC, 2015)

Significance of
Pathophysiology
CHIKV has rapidly spread
throughout temperate and tropical
climates around the world. During the
epidemic initiated in St. Martin with
CHIKV Asian genotype in 2013, nearly
one million people were infected
throughout the Americas (Halstead,
2015). The need to develop rapid
detection protocol and anticipate
outbreaks before occurrence will lead to
reduced infectivity (Prat et al., 2014).
Primary prevention is currently
protection of humans from exposure to
mosquitos, but further prevention
requires protecting humans ill with
CHIKV from exposure to further
mosquito bites (CDC, 2015).

The transmission cycle is host-mosquito-host, meaning that an infected host is bitten by a vector whom then bites
another host and deposits the infection (CDC, 2015). CHIKV spreads rapidly in urban environments where the
mosquito has multiple hosts in close proximity with high virulence (Sharp et al., 2014). After transmission, the
incubation period in the host is 3-7 days, with virus replication starting in the skin and traveling to the liver and
joints through the blood stream (Weaver, Osorio, Livengood, Chen, & Stinchcomb. 2012). CHIKV is detected
through serum specimen by real-time reverse transcription-polymerase chain reaction (rPT-PCR) test within five
days of symptom onset or IgM capture enzyme-linked immunosorbent assay (MAC-ELISA) at the sixth day and
beyond (Sharp et. al., 2014). Once a host is infected, protection from CHIKV with long-term immunity is noted
(Sharp et al., 2014).

Signs and Symptoms
•

Table 2.
Reported
chikungunya
cases and
number of
countries/
territories
with local
transmission
in the
Americas, Dec
2013– Mar
2015 (CDC,
2015)

Chikungunya means “that which
bends up” in the Makonde language
spoken in Tanzania and Mozambique
(Halstead, 2015). The tribe that gave
CHIKV the current name is a short 24hour trip via modern travel from the
United States. Ease of travel and global
economy have brought CHIKV to areas
that are not home to aedes aegypti and
aedes albopictus. Health care providers
must continue to educate themselves on
emerging diseases such as CHIKV, for
they are at the forefront of education,
prevention, research, detection and
treatment. Who knows, the next case of
CHIKV may be detected by you.

References
Implications for
Nursing Care

The author was first alerted to CHIKV during a trip abroad. A poster depicting the CHIKV rash and CHIKV
transmission information were presented in an international airport. After many visits to East Africa and
Central America, the author is interested in practicing in a foreign clinic where CHIKV is currently
diagnosed in the population. To many people in the regions affected by CHIKV, there are limited resources
to healthcare, education, and nutrition. Simple acts like mosquito nets, long sleeve shirts, and removal of
stagnant water may keep food on the table for struggling families, kids in school, and medical facilities
from overcrowding. After initial research, it is evident that CHIKV could become a more widespread
disease in the U.S. at any time. With no vaccination available and symptom management as the only
treatment, more work must be done to educate healthcare providers and define a detection and treatment
plan with reliable outcomes around the world.

Conclusion

•

•

The two hallmark symptoms of
CHIKV are fever and
polyarthralgia effecting bilateral
joints (Staples & Fischer, 2014)).
Symptoms also include headache,
rash, muscle pain, and nausea
and typically subside within two
weeks (Harvey, 2015).
Foissac, Javelle, Ray, Guérin, and
Simon (2015) report that two
recent epidemics of CHIKV are
known to cause postchikungunya rheumatoid
arthritis.

•

•

Five percent of individuals suffering
from CHIKV will suffer from postchikungunya rheumatoid arthritis
lasting more than three months and
experiencing pain and impaired
mobility
(Foissac, Javelle, Ray, Guérin, &
Simon, 2015). Death occurs
infrequently and has been reported
in less than one percent of cases,
most often plaguing older adults with
comorbid conditions (Staples &
Fischer, 2014).

Nurses should be aware that CHIKV
is transmitted from mosquitos in the
United States (CDC, 2015). The idea that
CHIKV is isolated in Asia, Africa, and
South America is outdated and
dangerous. Any patient that has
traveled to tropical or temperate
climates, where aedes aegypti and aedes
albopictus are present, is at risk for
developing CHIKV (CDC, 2015). Health
care providers should consider possible
CHIKV transmission for any patient
presenting with polyarthralgia, fever,
and rash.
No vaccine
or medication will prevent the disease at
this time, but many steps can be taken to
decrease the likelihood of contracting
the virus (Prat et. al., 2014). Nurses
should instruct patients living or
traveling in CHIKV outbreak locations on
preventative measures. People living or
traveling in these areas should cover
with long sleeve clothing when outside,
use mosquito repellant with DEET,
utilize air-conditioning if available, keep
screens on doors and windows, and
empty any standing water from
containers (CDC, 2015). If a patient
develops signs of CHIKV, the patient
should maintain strict avoidance of the
mosquito vector in the first week (CDC,
2015).
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